{"id":496342,"date":"2021-05-20T08:03:46","date_gmt":"2021-05-20T12:03:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/"},"modified":"2021-05-20T08:03:46","modified_gmt":"2021-05-20T12:03:46","slug":"lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/","title":{"rendered":"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, May  20, 2021  (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton LLP (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gkHBMuJdnG6udaF_UtTdbYdTBqxTTMV1lpnzWcW1UYmcmOMyftji49Wq_UA9BB7AIgXNtdnIktkSKHh1TkoFp4i2swZ07ki24K8ZfR6WFFk=\" rel=\"nofollow noopener\" target=\"_blank\">www.blockleviton.com<\/a>), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against ChemoCentryx, Inc. (NASDAQ: CCXI) and certain of its executives for securities fraud. Investors who purchased ChemoCentryx shares between November 26, 2019 and May 3, 2021, and who lost money are strongly encouraged to contact Block &amp; Leviton attorneys at (617) 398-5600, via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AJn0fq3_o1vOJb80lj_I_jwbzkNIusGNdFzirGZVTZYiUA4nM7i3ee2gOYrjceCRuRsaUn2ZbqbwwkZyNc_XdPF0Byz3D4hew1fvFhrCv30=\" rel=\"nofollow noopener\" target=\"_blank\">cases@blockleviton.com<\/a>, or to visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=doi41C9mSKWrhxVPLyQuuTlydaxhfbrlnAOMQCSfBbuwi8y_bmDQulVLuFR9PYUcO-TzyyZduC5AuosMMIr7xwz_xbsf08gSp3hKQFRAX2M=\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a> for information on the case. The deadline to seek appointment as lead plaintiff is July 6, 2021.<\/p>\n<p align=\"justify\">On May 4, 2021, the U.S. Food and Drug Administration released a \u201cBriefing Document\u201d concerning ChemoCentryx\u2019s drug candidate avacopan, which is in development for the treatment of adult patients with anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis. To support its New Drug Application for avacopan, ChemoCentryx relied primarily upon its Phase III ADVOCATE study. In the Briefing Document, the FDA wrote that \u201c[c]omplexities of the study design . . . raise questions about the interpretability of the data to define a clinically meaningful benefit of avacopan and its role in the management of\u201d ANCA vasculitis. The FDA further wrote that it had \u201cidentified several areas of concern, raising uncertainty about the interpretability of the[] data and the clinical meaningfulness of these results . . . .\u201d On this news, shares of ChemoCentryx stock fell approximately 45% in one day, after plummeting by over 60% during intraday trading on May 4, 2021.<\/p>\n<p align=\"justify\">The lawsuit was filed in the U.S. District Court for the Northern District of California. The case is captioned <em>Homyk v. ChemoCentryx, Inc., et al.<\/em>, No. 3:21-cv-03343 (N.D. Cal.), and has not yet been assigned to a specific judge or courthouse. The class period is between November 26, 2019 and May 3, 2021, inclusive. A class has not yet been certified, and until a certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.<\/p>\n<p align=\"justify\">If you purchased or acquired ChemoCentryx shares between November 26, 2019 and May 3, 2021 and have questions about your legal rights or possess information relevant to this matter, please contact Block &amp; Leviton attorneys at (617) 398-5600, via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AJn0fq3_o1vOJb80lj_I_jwbzkNIusGNdFzirGZVTZZRfE9Et6cSchWq_qme_a5YNaD4fhn6Nic_SdMOKGVxZXx8zGY3vS4xje9HUIpYrDk=\" rel=\"nofollow noopener\" target=\"_blank\">cases@blockleviton.com<\/a>, or visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=doi41C9mSKWrhxVPLyQuuYDMZEna4xBPQaMCLoEvHOkJVhpvY7fMm-nIhN-03MbQlhQbQOSSWCoV5cvvVMNCwJcWfEPYFOQCYHiQPXzflAY=\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a>. The deadline to seek appointment as lead plaintiff is July 6, 2021.<\/p>\n<p align=\"justify\">Block &amp; Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the country\u2019s financial markets. The firm represents many of the nation\u2019s largest institutional investors as well as individual investors in securities litigation throughout the United States. The firm\u2019s lawyers have recovered billions of dollars for its clients.<\/p>\n<p>This notice may constitute attorney advertising.<\/p>\n<p>CONTACT:<br \/>BLOCK &amp; LEVITON LLP<br \/>260 Franklin St., Suite 1860<br \/>Boston, MA 02110<br \/>Phone: (617) 398-5600<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AJn0fq3_o1vOJb80lj_I_jwbzkNIusGNdFzirGZVTZYBoKmorhRbbDXPo8cE3OvGkUJ6EQFI7CfZTkvIVMNe0VH9XcrXlagIvo-AD_m0j98=\" rel=\"nofollow noopener\" target=\"_blank\">cases@blockleviton.com<\/a><br \/>SOURCE: Block &amp; Leviton LLP<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gkHBMuJdnG6udaF_UtTdbSGkwKb1cjt_jMQdSkFqGb-gy0l6mqIXBolGIOAQlGK4wHaBIoNwDWZPJdhP9u8P6Lbxu1pzhkH-v4tOTa7YvK0=\" rel=\"nofollow noopener\" target=\"_blank\">www.blockleviton.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f2599282-de06-414f-ad79-4951101d3481\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, May 20, 2021 (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against ChemoCentryx, Inc. (NASDAQ: CCXI) and certain of its executives for securities fraud. Investors who purchased ChemoCentryx shares between November 26, 2019 and May 3, 2021, and who lost money are strongly encouraged to contact Block &amp; Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or to visit our website for information on the case. The deadline to seek appointment as lead plaintiff is July 6, 2021. On May 4, 2021, the U.S. Food and Drug Administration released a \u201cBriefing Document\u201d concerning ChemoCentryx\u2019s drug candidate avacopan, which is in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-496342","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, May 20, 2021 (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against ChemoCentryx, Inc. (NASDAQ: CCXI) and certain of its executives for securities fraud. Investors who purchased ChemoCentryx shares between November 26, 2019 and May 3, 2021, and who lost money are strongly encouraged to contact Block &amp; Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or to visit our website for information on the case. The deadline to seek appointment as lead plaintiff is July 6, 2021. On May 4, 2021, the U.S. Food and Drug Administration released a \u201cBriefing Document\u201d concerning ChemoCentryx\u2019s drug candidate avacopan, which is in &hellip; Continue reading &quot;LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-20T12:03:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm\",\"datePublished\":\"2021-05-20T12:03:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/\"},\"wordCount\":480,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/\",\"name\":\"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=\",\"datePublished\":\"2021-05-20T12:03:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/","og_locale":"en_US","og_type":"article","og_title":"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - Market Newsdesk","og_description":"BOSTON, May 20, 2021 (GLOBE NEWSWIRE) &#8212; Block &amp; Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against ChemoCentryx, Inc. (NASDAQ: CCXI) and certain of its executives for securities fraud. Investors who purchased ChemoCentryx shares between November 26, 2019 and May 3, 2021, and who lost money are strongly encouraged to contact Block &amp; Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or to visit our website for information on the case. The deadline to seek appointment as lead plaintiff is July 6, 2021. On May 4, 2021, the U.S. Food and Drug Administration released a \u201cBriefing Document\u201d concerning ChemoCentryx\u2019s drug candidate avacopan, which is in &hellip; Continue reading \"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-20T12:03:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm","datePublished":"2021-05-20T12:03:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/"},"wordCount":480,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/","name":"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=","datePublished":"2021-05-20T12:03:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTg2OSM0MTkzMjY0IzIwMTgxMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lawsuit-filed-block-leviton-llp-has-filed-a-lawsuit-against-chemocentryx-inc-for-securities-fraud-investors-who-lost-money-should-contact-the-firm-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"LAWSUIT FILED: Block &amp; Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/496342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=496342"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/496342\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=496342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=496342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=496342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}